Articles
Helio Genomics to showcase results from CLiMB Pivotal Trial in an oral presentation at the EASL Congress 2024
The primary goals of the study were to evaluate the sensitivity and specificity of HelioLiver compared to ultrasound for the detection of HCC within a population at high risk of
May 21, 2024